{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:35:11Z","timestamp":1792798511717,"version":"4.5.0"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Invasive liver abscess (ILA) represents a formidable clinical challenge, characterized by rapidly evolving hepatic lesions and systemic dissemination. The gut\u2013liver axis, a vital conduit for immune and metabolic regulation, has emerged as a central driver of its pathogenesis. This narrative review draws on insights from select transcriptomic, proteomic, metabolomic, and microbiomic studies, revealing how chronic antibiotic use, unhealthy diets, and lingering pathological conditions disrupt intestinal barrier integrity and perturb bile acid and short-chain fatty acid metabolism. This dysregulated microenvironment facilitates bacterial translocation into the liver, triggering a robust inflammatory cascade and the upregulation of virulence factors involved in capsule synthesis and biofilm formation. Evidence suggests microbial dysbiosis contributes to hepatic immune dysregulation. These insights pave the way for novel ILA interventions. This review offers original insights by critically integrating evidence from transcriptomic, proteomic, metabolomic, and microbiomic studies with GRADE-evaluated clinical data, proposing a novel bacteria\u2013inflammation\u2013virulence feedback loop and precision therapeutic frameworks that target the gut-liver axis, filling gaps in traditional ILA models and guiding future interventions.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1646893","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:29:48Z","timestamp":1761715788000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Gut\u2013liver axis dysregulation and microbial dysbiosis in invasive liver abscess: a narrative review"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoshuai","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(24)00737-2","article-title":"Invasive liver abscess syndrome with central\u00a0nervous system involvement caused by hypermucoviscous Klebsiella pneumoniae: positive string test","volume":"403","author":"de Oliveira Franco","year":"2024","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ismejo\/wrae054","article-title":"Hypervirulent Klebsiella pneumoniae employs genomic island encoded toxins against bacterial competitors in the gut","volume":"18","author":"Tan","year":"2024","journal-title":"ISME J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.12890\/2018_000800","article-title":"Klebsiella pneumoniae invasive syndrome","volume":"5","author":"Evangelista","year":"2018","journal-title":"Eur J Case Rep Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut-liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0135","article-title":"A gut-vascular barrier controls the systemic dissemination of bacteria","volume":"350","author":"Spadoni","year":"2015","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/ijms22031397","article-title":"Bile acids and microbiota: multifaceted and versatile regulators of the liver-Gut axis","volume":"22","author":"Gruner","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1949095","article-title":"Effect of different bile acids on the intestine through enterohepatic circulation based on FXR","volume":"13","author":"Xiang","year":"2021","journal-title":"Gut Microbes"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13355","article-title":"Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: A randomized clinical trial","volume":"326","author":"Johnstone","year":"2021","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660179","article-title":"The role of the gut-Liver axis in metabolic dysfunction-Associated fatty liver disease","volume":"12","author":"Martin-Mateos","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0857","article-title":"Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer","volume":"31","author":"Li","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.46405","article-title":"The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases","volume":"16","author":"Yang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the intestinal microbiome and gut barrier to hepatic disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/biology13040243","article-title":"Intestinal barrier dysfunction and gut microbiota in non-Alcoholic fatty liver disease: assessment, mechanisms, and therapeutic considerations","volume":"13","author":"Long","year":"2024","journal-title":"Biol (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"A507","DOI":"10.1016\/j.chest.2020.08.483","article-title":"Attack of the klebsiella: A case of invasive liver abscess syndrome with multi-organ dissemination","volume":"158","author":"Torres","year":"2020","journal-title":"Chest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1092879","article-title":"Successful hepatic resection for invasive Klebsiella pneumoniae large multiloculated liver abscesses with percutaneous drainage failure: A case report","volume":"9","author":"Nojima","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.02.008","article-title":"Disparate domains: cryptogenic invasive Klebsiella pneumoniae liver abscess syndrome","volume":"130","author":"Sink","year":"2017","journal-title":"Am J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00515","article-title":"Klebsiella pneumoniae in Singapore: hypervirulent infections and the carbapenemase threat","volume":"7","author":"Chew","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12050661","article-title":"Clinical spectrum and outcomes of cryptogenic Klebsiella pneumoniae liver abscess in the Americas: A scoping review","volume":"12","author":"Cardenas-Alvarez","year":"2023","journal-title":"Pathogens"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29463","article-title":"Demographics and prognosis of patients with pyogenic liver abscess due to Klebsiella pneumonia or other species","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106767","article-title":"Differences in severity of bacteraemia caused by hypermucoviscous and non-hypermucoviscous Klebsiella pneumoniae","volume":"61","author":"Namikawa","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"B21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12866-023-03124-0","article-title":"Identification of hypervirulent Klebsiella pneumoniae based on biomarkers and Galleria mellonella infection model","volume":"23","author":"Mai","year":"2023","journal-title":"BMC Microbiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S461903","article-title":"Virulence factors and carbapenem-resistance mechanisms in hypervirulent Klebsiella pneumoniae","volume":"17","author":"Liao","year":"2024","journal-title":"Infect Drug Resist"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70205-0","article-title":"Klebsiella pneumoniae liver abscess: a new invasive syndrome","volume":"12","author":"Siu","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.714916","article-title":"Case report: diagnosis of Klebsiella pneumoniae invasive liver abscess syndrome with purulent meningitis in a patient from pathogen to lesions","volume":"8","author":"Zeng","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.08.1928","article-title":"Invasive liver abscess syndrome as a consequence of Klebsiella pneumoniae urinary tract infection in a nondiabetic American caucasian male: a case report","volume":"156","author":"Young","year":"2019","journal-title":"Chest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1467197","article-title":"Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights","volume":"15","author":"Wang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00284-024-03694-w","article-title":"Microbiota and gut-liver axis: an unbreakable bond","volume":"81","author":"Sivaprasadan","year":"2024","journal-title":"Curr Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1159\/000535962","article-title":"Exploring the relationship between liver disease, bacterial translocation, and dysbiosis: unveiling the gut-Liver axis","volume":"40","author":"Juanola","year":"2024","journal-title":"Visc Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2022.00089","article-title":"Intestinal barrier function in the pathogenesis of nonalcoholic fatty liver disease","volume":"11","author":"Liu","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/jas\/skad242","article-title":"Short communication: evaluation of an endotoxin challenge and intraruminal bacterial inoculation model to induce liver abscesses in Holstein steers","volume":"101","author":"McDaniel","year":"2023","journal-title":"J Anim Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40560-025-00786-y","article-title":"Gut integrity in intensive care: alterations in host permeability and the microbiome as potential therapeutic targets","volume":"13","author":"Oami","year":"2025","journal-title":"J Intensive Care"},{"key":"B32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13054-022-04090-1","article-title":"The gut-liver axis in sepsis: interaction mechanisms and therapeutic potential","volume":"26","author":"Zhang","year":"2022","journal-title":"Crit Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"8351","DOI":"10.3390\/ijms21218351","article-title":"The gut barrier, intestinal microbiota, and liver disease: molecular mechanisms and strategies to manage","volume":"21","author":"Plaza-Diaz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/jir.S334581","article-title":"Gut microbiota contributes to host defense against klebsiella pneumoniae-induced liver abscess","volume":"14","author":"Zheng","year":"2021","journal-title":"J Inflammation Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jim.2014.12.015","article-title":"Methods to determine intestinal permeability and bacterial translocation during liver disease","volume":"421","author":"Wang","year":"2015","journal-title":"J Immunol Methods"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001871","article-title":"Management of pyogenic liver abscesses: contemporary strategies and challenges","volume":"57","author":"Lam","year":"2023","journal-title":"J Clin Gastroenterol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/ph18050724","article-title":"Hypervirulent Klebsiella pneumoniae: Insights into Virulence, Antibiotic Resistance, and Fight Strategies Against a Superbug","volume":"18","author":"Hetta","year":"2025","journal-title":"Pharm (Basel)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2025.102717","article-title":"Successful treatment of an intra-abdominal abscess caused by KPC-2-producing hypervirulent Klebsiella pneumoniae sequence type 11 with imipenem\/cilastatin\/relebactam in a Japanese patient","volume":"31","author":"Ishikawa","year":"2025","journal-title":"J Infect Chemother"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112338-20241026-00663","article-title":"Pangenome analysis on plasmids carried by hypervirulent Klebsiella pneumoniae","volume":"46","author":"Wu","year":"2025","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-24957","article-title":"Prevalence, Risk Factors, and Clinical Outcomes of Hypervirulent Klebsiella pneumoniae Strains among Klebsiella pneumoniae Infections: A Systematic Review and Meta-analysis","volume":"29","author":"Nagendra","year":"2025","journal-title":"Indian J Crit Care Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0261-4","article-title":"Epithelial Toll-like receptors and their role in gut homeostasis and disease","volume":"17","author":"Burgue\u00f1o","year":"2020","journal-title":"Nat Rev Gastro Hepat"},{"key":"B43","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/nu10080988","article-title":"The potential of gut commensals in reinforcing intestinal barrier function and alleviating inflammation","volume":"10","author":"Hiippala","year":"2018","journal-title":"Nutrients"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e1002533","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised estimates for the number of human and bacteria cells in the body","volume":"14","author":"Sender","year":"2016","journal-title":"PloS Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1992.262.6.L647","article-title":"Structure, function, and regulation of cellular tight junctions","volume":"262","author":"Schneeberger","year":"1992","journal-title":"Am J Physiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.123.6.1631","article-title":"Breaking through the tight junction barrier","volume":"123","author":"Gumbiner","year":"1993","journal-title":"J Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb05235.x","article-title":"The structure and function of claudins, cell adhesion molecules at tight junctions","volume":"915","author":"Tsukita","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2003.08.007","article-title":"Regulation of tight junctions and loss of barrier function in pathophysiology","volume":"36","author":"Harhaj","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2007.07.012","article-title":"Adherens and tight junctions: structure, function and connections to the actin cytoskeleton","volume":"1778","author":"Hartsock","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201242543","article-title":"Epithelial-microbial crosstalk in polymeric Ig receptor deficient mice","volume":"42","author":"Reikvam","year":"2012","journal-title":"Eur J Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2943-4","article-title":"An insight into gut microbiota and its functionalities","volume":"76","author":"Adak","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2012.02.002","article-title":"Homeland security: IgA immunity at the frontiers of the body","volume":"33","author":"Macpherson","year":"2012","journal-title":"Trends Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3945\/jn.109.104638","article-title":"Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers","volume":"139","author":"Peng","year":"2009","journal-title":"J Nutr"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29676","article-title":"Modulation of the intestinal bile acid\/farnesoid X receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice","volume":"67","author":"Hartmann","year":"2018","journal-title":"Hepatology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0255","article-title":"Bile acids and the membrane bile acid receptor TGR5\u2013connecting nutrition and metabolism","volume":"18","author":"Thomas","year":"2008","journal-title":"Thyroid"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186892","article-title":"Regulation of short-chain fatty acids in the immune system","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-025-01183-w","article-title":"Gut microbiota-derived short-chain fatty acids and their role in human health and disease","volume":"23","author":"Mukhopadhya","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.007","article-title":"Targeting the gut-liver axis in liver disease","volume":"67","author":"Wiest","year":"2017","journal-title":"J Hepatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.667066","article-title":"Unhealthy lifestyle and gut dysbiosis: A better understanding of the effects of poor diet and nicotine on the intestinal microbiome","volume":"12","author":"Martinez","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2509-x","article-title":"Mechanisms and consequences of intestinal dysbiosis","volume":"74","author":"Weiss","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1124118","article-title":"The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40168-022-01255-6","article-title":"The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids","volume":"10","author":"Xiao","year":"2022","journal-title":"Microbiome"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.718356","article-title":"Inflammatory and microbiota-related regulation of the intestinal epithelial barrier","volume":"8","author":"Barbara","year":"2021","journal-title":"Front Nutr"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0054-1","article-title":"Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis","volume":"15","author":"Man","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.04933.x","article-title":"Bacterial translocation: overview of mechanisms and clinical impact","volume":"22","author":"Balzan","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2018.1502786","article-title":"Endogenous endophthalmitis caused by carbapenem-Resistant hypervirulent Klebsiella pneumoniae: A case report and literature review","volume":"27","author":"Zhou","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01127-16","article-title":"High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance","volume":"60","author":"Zhang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1147855","article-title":"Hypercapsule is the cornerstone of Klebsiella pneumoniae in inducing pyogenic liver abscess","volume":"13","author":"Hu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/microorganisms9061282","article-title":"From Klebsiella\u00a0pneumoniae colonization to dissemination: an overview of studies implementing murine models","volume":"9","author":"Joseph","year":"2021","journal-title":"Microorganisms"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.2174\/13816128130307","article-title":"Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target","volume":"19","author":"Miele","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B73","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mib.2020.01.006","article-title":"The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae","volume":"54","author":"Walker","year":"2020","journal-title":"Curr Opin Microbiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0136323","DOI":"10.1128\/msystems.01363-23","article-title":"Adaptive attenuation of virulence in hypervirulent carbapenem-resistant Klebsiella pneumoniae","volume":"9","author":"Teng","year":"2024","journal-title":"mSystems"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00570-19","article-title":"Immunomodulatory Effects of Lactobacillus plantarum on Inflammatory Response Induced by Klebsiella pneumoniae","volume":"87","author":"Vareille-Delarbre","year":"2019","journal-title":"Infect Immun"},{"key":"B76","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s12879-022-07648-0","article-title":"Pyogenic liver abscess-caused Klebsiella pneumoniae in a tertiary hospital in China in 2017: implication of hypervirulent carbapenem-resistant strains","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Infect Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3390\/pathogens11090976","article-title":"Demographics, Radiological Findings, and Clinical Outcomes of Klebsiella pneumonia vs. Non-Klebsiella pneumoniae Pyogenic Liver Abscess: A Systematic Review and Meta-Analysis with Trial Sequential Analysis","volume":"11","author":"Chan","year":"2022","journal-title":"Pathogens"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3138\/jammi-2023-0004","article-title":"Antibiotic treatment durations for pyogenic liver abscesses: A systematic review","volume":"8","author":"Curran","year":"2023","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231180053","article-title":"Clinical manifestations, diagnosis, treatment, and outcome\u00a0of\u00a0pyogenic liver abscess: a retrospective study","volume":"51","author":"Wang","year":"2023","journal-title":"J Int Med Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4067\/S0716-10182020000500566","article-title":"Invasive liver abscess syndrome caused by Klebsiella pneumoniae, case series","volume":"37","author":"Lapidus","year":"2020","journal-title":"Rev Chil Infectol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1186\/s12879-025-10981-9","article-title":"Analysis of clinical and microbiological characteristics of invasive Klebsiella pneumoniae liver abscess syndrome","volume":"25","author":"Gu","year":"2025","journal-title":"BMC Infect Dis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz881","article-title":"Oral vs Intravenous Antibiotics for Patients With Klebsiella pneumoniae Liver Abscess: A Randomized, Controlled Noninferiority Study","volume":"71","author":"Molton","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.946628","article-title":"The gut-liver axis in immune remodeling of\u00a0hepatic cirrhosis","volume":"13","author":"Guan","year":"2022","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"13375","DOI":"10.3892\/mmr.2024.13375","article-title":"Gut\u2212liver axis in liver disease: From basic science to clinical treatment (Review)","volume":"31","author":"Wang","year":"2025","journal-title":"Mol Med Rep"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e072736","DOI":"10.1136\/bmjopen-2023-072736","article-title":"Percutaneous catheter drainage versus percutaneous needle aspiration for liver abscess: a systematic review, meta-analysis and trial sequential analysis","volume":"13","author":"Lin","year":"2023","journal-title":"BMJ Open"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S515201","article-title":"Minimally invasive interventional therapy for liver abscess with bloodstream infection caused by a fishbone perforation of the stomach wall: A case report","volume":"18","author":"Zhang","year":"2025","journal-title":"Infect Drug Resist"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e20528","DOI":"10.7759\/cureus.20528","article-title":"Role of pigtail catheter drainage versus percutaneous needle aspiration in the management of liver abscess: A retrospective analysis","volume":"13","author":"Kumar","year":"2021","journal-title":"Cureus"},{"key":"B88","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.3390\/nu14153212","article-title":"Bile salt hydrolase-Competent probiotics in the management of IBD: unlocking the \u201cBile acid code","volume":"14","author":"Gadaleta","year":"2022","journal-title":"Nutrients"},{"key":"B89","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells12010184","article-title":"Probiotics mechanism of action on immune cells and beneficial effects on human health","volume":"12","author":"Mazziotta","year":"2023","journal-title":"Cells"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/nu12041107","article-title":"The effect of probiotics on the production of short-Chain fatty acids by human intestinal microbiome","volume":"12","author":"Markowiak-Kopec","year":"2020","journal-title":"Nutrients"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.3390\/ijms23052896","article-title":"Overview of the importance of\u00a0biotics\u00a0in gut barrier integrity","volume":"23","author":"Kocot","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B92","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12967-024-05832-1","article-title":"Fecal microbiota transplantation restores gut microbiota diversity in children with active Crohn\u2019s disease: a prospective trial","volume":"23","author":"Zou","year":"2025","journal-title":"J Transl Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e0006022","DOI":"10.1128\/cmr.00060-22","article-title":"Fecal microbiota transplantation: current challenges and future landscapes","volume":"37","author":"Yadegar","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"B94","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40168-023-01623-w","article-title":"Recipient-independent, high-accuracy FMT-response prediction and optimization in mice and humans","volume":"11","author":"Shtossel","year":"2023","journal-title":"Microbiome"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1439176","article-title":"Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review","volume":"15","author":"Karimi","year":"2024","journal-title":"Front Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.3390\/jcm13133977","article-title":"Revolutionizing gastrointestinal disorder management: cutting-Edge advances and future prospects","volume":"13","author":"Suri","year":"2024","journal-title":"J Clin Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1264779","article-title":"Efficacy and safety of fecal microbiota transplantation for the treatment of irritable bowel syndrome: an overview of overlapping systematic reviews","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103036","article-title":"Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis","volume":"141","author":"Porcari","year":"2023","journal-title":"J Autoimmun"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000865424.73697.ab","article-title":"S2196\u2003A novel treatment approach to treatment-resistant, recurrent Clostridioides difficile","volume":"117","author":"Kottapalli","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41571-025-01026-w","article-title":"Roles of the gut microbiota in immune-related adverse events: mechanisms and therapeutic intervention","volume":"22","author":"Gao","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/frabi.2023.1093156","article-title":"Resistance-resistant antibacterial treatment strategies","volume":"2","author":"Batchelder","year":"2023","journal-title":"Front Antibiot"},{"key":"B102","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41522-025-00678-x","article-title":"Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation","volume":"11","author":"Sun","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14040345","article-title":"Targeting gene transcription prevents antibiotic resistance","volume":"14","author":"Agris","year":"2025","journal-title":"Antibiotics"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3390\/gidisord7010007","article-title":"Microbiome-Driven therapeutics: from gut health to precision medicine","volume":"7","author":"Yaqub","year":"2025","journal-title":"Gastrointest Disord"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2356680","article-title":"Clinical features and risk factors for pyogenic liver abscess caused by multidrug-resistant organisms: A retrospective study","volume":"15","author":"Long","year":"2024","journal-title":"Virulence"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.16.17713","article-title":"Liver abscesses: factors that influence outcome of percutaneous drainage","volume":"209","author":"Haider","year":"2017","journal-title":"Am J Roentgenol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01964-3","article-title":"Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases","volume":"28","author":"Ianiro","year":"2022","journal-title":"Nat Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3390\/nu16183061","article-title":"Biomarkers for health functional foods in metabolic dysfunction-associated steatotic liver disorder (MASLD) prevention: an integrative analysis of network pharmacology, gut microbiota, and multi-omics","volume":"16","author":"Yuan","year":"2024","journal-title":"Nutrients"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.966329","article-title":"Artificial intelligence for precision medicine in autoimmune liver disease","volume":"13","author":"Gerussi","year":"2022","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2022.0079","article-title":"Multi-Omics and artificial intelligence-Guided data integration in chronic liver disease: prospects and challenges for precision medicine","volume":"26","author":"Lin","year":"2022","journal-title":"OMICS"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/jcm14051536","article-title":"Paradigm shift\u00a0in\u00a0inflammatory bowel disease management: precision medicine, artificial intelligence, and emerging therapies","volume":"14","author":"Caballero Mateos","year":"2025","journal-title":"J Clin Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15415","article-title":"Artificial intelligence in precision medicine in hepatology","volume":"36","author":"Su","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188989","article-title":"Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2349768","article-title":"Genetic, virulence, and antimicrobial resistance characteristics associated with distinct morphotypes in ST11 carbapenem-resistant Klebsiella pneumoniae","volume":"15","author":"Chen","year":"2024","journal-title":"Virulence"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1407219","article-title":"Molecular characteristics and pathogenic mechanisms of KPC-3 producing hypervirulent carbapenem-resistant Klebsiella pneumoniae (ST23-K1)","volume":"14","author":"Tu","year":"2024","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1646893\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:29:50Z","timestamp":1761715790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1646893\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":115,"alternative-id":["10.3389\/fimmu.2025.1646893"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1646893","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1646893"}}